Literature DB >> 15688277

Dengue and dengue vaccines.

Robert Edelman.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15688277     DOI： 10.1086/427784

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

Review 1.  Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas.

Authors:  G William Letson; Pratap Singhasivanon; Eduardo Fernandez; Nihal Abeysinghe; Juan Jose Amador; Harold S Margolis; Robert Edelman
Journal:  Hum Vaccin       Date:  2010-10-01

2.  Ecological and immunological determinants of dengue epidemics.

Authors:  Helen J Wearing; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

3.  Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Authors:  David E Clements; Beth-Ann G Coller; Michael M Lieberman; Steven Ogata; Gordon Wang; Kent E Harada; J Robert Putnak; John M Ivy; Michael McDonell; Gary S Bignami; Iain D Peters; Julia Leung; Carolyn Weeks-Levy; Eileen T Nakano; Tom Humphreys
Journal:  Vaccine       Date:  2010-01-22       Impact factor: 3.641

4.  An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice.

Authors:  Laura J White; Melissa M Parsons; Alan C Whitmore; Brandon M Williams; Aravinda de Silva; Robert E Johnston
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

5.  Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy.

Authors:  Katherine M Smith; Kavita Nanda; Carla J Spears; Amanda Piper; Mariana Ribeiro; Michelle Quiles; Caitlin M Briggs; Gwynneth S Thomas; Malcolm E Thomas; Dennis T Brown; Raquel Hernandez; Victoria McCarl
Journal:  Am J Trop Med Hyg       Date:  2012-08-13       Impact factor: 2.345

6.  DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.

Authors:  Adriana S Azevedo; Anna M Y Yamamura; Marcos S Freire; Gisela F Trindade; Myrna Bonaldo; Ricardo Galler; Ada M B Alves
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

7.  Spatial patterns and socioecological drivers of dengue fever transmission in Queensland, Australia.

Authors:  Wenbiao Hu; Archie Clements; Gail Williams; Shilu Tong; Kerrie Mengersen
Journal:  Environ Health Perspect       Date:  2011-10-20       Impact factor: 9.031

8.  Dengue disease surveillance: improving data for dengue control.

Authors:  Olaf Horstick; Amy C Morrison
Journal:  PLoS Negl Trop Dis       Date:  2014-11-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.